Letter From the Editor
Letter From the Editor: Addressing the Racial Gap in Health Care
Feature Article
Antibody-Drug Conjugates in Advanced Lung Cancer: Is This a New Frontier?
Abstract: Over the past decade, the lung cancer landscape has been dominated by targeted and immunotherapeutic approaches that have drastically shifted treatment paradigms for patients with […]
In This Issue
From Recent Issues
Feature Article
Antibody-Drug Conjugates in Advanced Lung Cancer: Is This a New Frontier?
Abstract: Over the past decade, the lung cancer landscape has been dominated by targeted and immunotherapeutic approaches that have drastically shifted treatment paradigms for patients with […]
Feature Article
Redefining the Standard of Care for Low-Grade Serous Ovarian Cancer
Abstract: Low-grade serous carcinoma is a rare epithelial ovarian cancer subtype with distinct clinical, histologic, and molecular features. Improved understanding of this disease subtype has prompted […]
Feature Article
Immune Checkpoint Inhibitor Therapy in Locally Advanced MSI GI Malignancies
Abstract: Locally advanced gastrointestinal (GI) malignancies have conventionally been treated in a multimodal fashion that combines (neo)adjuvant chemotherapy with or without radiation and definitive surgical resection. […]
Supplements
Colorectal cancer
Improving Survival in Metastatic Colorectal Cancer Through Optimized Patient Selection
Abstract: The systemic treatment options for patients with metastatic colorectal cancer have recently expanded with the US Food and Drug Administration approval of fruquintinib being added to […]
Chronic lymphocytic leukemia
Highlights in Chronic Lymphocytic Leukemia From the 65th ASH Annual Meeting and Exposition
A Review of Selected Presentations From ASH 2023 December 9-12, 2023 • San Diego, California Acalabrutinib ± Obinutuzumab vs Obinutuzumab + Chlorambucil in Treatment-Naive Chronic […]
triple-negative breast cancer
Year-End Highlights in Metastatic Triple-Negative Breast Cancer from the 2022 American Society of Clinical Oncology Annual Meeting, and the European Society for Medical Oncology Congress and Breast Cancer Congress
A Review of Selected Presentations from ASCO 2022, Chicago, IL, June 3-7, 2022; ESMO Breast Cancer Congress 2022, Berlin, Germany, May 3-5 2022; and ESMO Congress […]